AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Starting retirement planning in your 20s allows for more savings and compound growth. Understand the benefits of early investment for a secure future.
22,999 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
NVIDIA's CEO hints that the next wave of wealth could come from skilled trades like plumbing and electrical work, pro...
NOWPayments and KoinX launch Crypto Tax Educational Assets to help global merchants navigate crypto tax rules as cros...
A veteran journalist says that while IPO chatter around OpenAI persists, the path to a public listing is longer and m...
Anthropic accuses Alibaba of distillation tactics to train rival systems, prompting fresh worries about frontier AI m...
El Salvador continues to pursue a plan to buy one Bitcoin per day, even as an IMF loan program restricts public-secto...
Tavant launches a new agentic AI platform aimed at accelerating loan software development, data modernization, and au...
Ripple's former CTO unveiled a two-component ReservedTxns concept aimed at preventing front-running on XRPL's native ...
AI-generated listing videos are reshaping real estate marketing, but new disclosures aim to curb misrepresentation. T...
Analysts warn that the CLARITY Act's odds of passing have fallen below 50% as the Senate's August recess approaches. ...
Lizex.io announces a global B2B partnership program, linking crypto wallets, rate aggregators, and fintech apps to it...
June payroll gains undershot forecasts, with revisions cooling prior months and participation slipping. The report le...